Cervical and anal HPV infections in HIV positive women and men

Virus Research

Volumn 89, Issue 2, 2002, Pages 201-211

  De Sanjosé, Silvia ^a   Palefsky, Joel ^b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal and cervical lesions; HIV; HPV

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

ANUS DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0036848957     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00189-2     Document Type: Conference Paper

References (44)

1. Ahdieh L., Munoz A., Vlahov D., Trimble C.L., Timpson L.A., Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and-seronegative women. Am. J. Epidemiol. 151:(12):2000;1148-1157.
2. Bayo S., Bosch F.X., de Sanjose S., Munoz N., Combita A.L., Coursaget P., Diaz M., Dolo A., van Den Brule A.J., Meijer C.J. Risk factors of invasive cervical cancer in Mali. Int. J. Epidemiol. 31:(1):2002;202-209.
3. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:(4):2002;244-265.
4. Clarke B., Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 82:(2):2001;238-246.
5. Cleary R., Schaldenbrand J., Fowler J., et al. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis. Colon Rectum. 42:1999;945-951.
6. Critchlow C.W., Surawicz C.M., Holmes K.K., et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 9:1995;255-1262.
7. Daling J.R., Weiss N.S., Hislop T.G., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. New Engl. J. Med. 317:1987;973-977.
8. dal Maso L., Serraino D., Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur. J. Cancer. 37:(10):2001;1188-1201.
9. Dillner J. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection. J. Clin. Virol. 19:(1-2):2000;7-23.
10. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., Wright T.C. Jr. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. J. Am. Med. Assoc. 283:(8):2000;1031-1037.
11. Franceschi S., dal Maso L., Arniani S., Crosignani P., Vercelli M., Simonato L., Falcini F., Zanetti R., Barchielli A., Serraino D., Rezza G. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br. J. Cancer. 78:(7):1998;966-970.
12. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 92:(18):2000;1500-1510.
13. Frisch M., Biggar R.J., Engels E., AIDS-Cancer Match Registry Study Group, et al. Association of cancer with AIDS-related immunosuppression in adults. J. Acquired Immune Defic. Syndr. 285:2001;1736-1745.
14. Gallagher B., Wang Z., Schymura M.J., Kahn A., Fordyce E.J. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am. J. Epidemiol. 154:(6):2001;544-556.
15. Gichangi P., De Vuyst H., Estambale B., Rogo K., Bwayo J., Temmerman M. HIV and cervical cancer in Kenya. Int. J. Gynaecol. Obstet. 76:(1):2002;55-63.
16. Goedert J.J., Cote T.R., Virgo P., et al. Spectrum of AIDS-associated malignant disorders. Lancet. 351:1998;1833-1839.
17. Goldie S.J., Kuntz K.M., Weinstein M.C., Freedberg K.A., Welton M.L., Palefsky J.M. The clinical-effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. J. Am. Med. Assoc. 281:1999;1822-1829.
18. Goldie S.J., Kuntz K.M., Weinstein M.C., Freedberg K.A., Palefsky J.M. The clinical benefits and cost-effectiveness of screening for anal squamous intraepithelial lesions and anal squamous cell cancer in homosexual and bisexual men. Am. J. Med. 108:2000;634-641.
19. Haga T., Kim S.-H., Jensen R.H., Darragh T., Palefsky J.M. Detection of genetic changes in anal intraepithelial neoplasia (AIN) of human immunodeficiency virus (HIV)-positive and HIV-negative men. J. Acquired Immune Defic. Syndr. 26:2001;256-262.
20. Hemminki K., Li X., Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur. J. Obstet. Gynecol. Reprod. Biol. 101:(1):2002;64-69.
21. Holly E.A., Ralston M.L., Darragh T.M., Greenblatt R.M., Jay N., Palefsky J.M. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J. Natl. Cancer Inst. 93:2001;843-849.
22. International Agency for Research on Cancer, 1996. IARC Working group on the evaluation of carcinogenic risk to humans. Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. IARC Monographs, vol. 66, Lyon, 1996.
23. International Collaboration on HIV and Cancer, 2000. Highly active antiretroviral therapy and incidence of cancer in human immnodeficiency virus-infected adults. J. Natl. Cancer Inst., 92, 1823-1830.
24. Jay N., Holly E.A., Berry M., Hogeboom C.J., Darragh T.M., Palefsky J.M. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis. Colon Rectum. 40:1997;919-928.
25. Lillo F., Ferrari D., Veglia F., et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J. Infect. Dis. 184:2001;547-551.
26. Mandelblatt J.S., Kanetsky P., Eggert L., Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia. Cancer Epidemiol. Biomark. Prev. 8:(1):1999;97-106.
27. Minkoff H., Ahdieh L., Massad L.S. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS. 15:2001;2157-2164.
28. Newton R., Beral V., Weiss R.A. Human immunodeficiency virus infection and cancer. Cancer Surveys Infections and Human Cancer. Imperial Cancer Research Fund. 1999;237-262 Cold Spring Harbor Laboratory Press, USA.
29. Nicoll A., Hughes G., Donnelly M., Livingstone S., De Angelis D., Fenton K., Evans B., Gill O.N., Catchpole M. Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex. Transm. Infect. 77:(4):2001;242-247.
30. Palefsky J.M., Holly E.A., Hogeboom C.J., Jay N., Berry M., Darragh T.M. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J. Acquired Immune Defic. Syndr. 14:1997;415-422.
31. Palefsky J.M., Holly E.A., Ralston M.L., Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in HIV-positive and HIV-negative homosexual men. J. Infect. Dis. 177:1998a;361-367.
32. Palefsky J.M., Holly E.A., Ralston M.L., Arthur S.P., Jay N., Berry J.M., DaCosta M.M., . Botts R., Darragh T.M. Anal squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J. Acquired Immune Defic. Syndr. 17:1998b;320-326.
33. Palefsky J.M., Holly E.A., Hogeboom C.J., Ralston M.L., DaCosta M.M., Botts R., Berry J.M., . Jay N., Darragh T.M. Viral, immunologic and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J. Acquired Immune Defic. Syndr. 17:1998c;314-319.
34. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., García P., Young M., Melnick S., Miotti P., Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative Women. J. Natl. Cancer Inst. 91:(3):1999;226-236.
35. Palefsky J.M., Holly E.A., Ralston M.L., Da Costa M., Greenblatt R.M. Prevalence and risk factors for anal HPV infection in HIV-positive and high-risk HIV-negative women. J. Infect. Dis. 183:2001;383-391.
36. Palefsky J.M., . Holly E.A., Ralston M.L., Da Costa M.M., . Bonner H., Jay N., Berry J.M., . Darragh T.M. The Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J. Acquired Immune Defic. Syndr. 28:2001;422-428.
37. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer. 94:2001;153-156.
38. Qualters J.R., Lee N.C., Smith R.A., et al. Breast and cervical cancer surveillance, United States, 1973-1987. Mor. Mortal Wkly. Rep. CDC Surveill Summ. 4:1992;1-7.
39. Selik R.M., Rabkin C.S. Cancer death rates associated with human immunodeficiency virus infection in the United States. J. Natl. Cancer Inst. 90:(17):1998;1300-1302.
40. Serraino D., Carrieri P., Pradier C., Bidoli E., Dorrucci M., Ghetti E., Schiesari A., Zucconi R., Pezzotti P., Dellamonica P., Franceschi S., Rezza G. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int. J. Cancer. 82:(3):1999;334-337.
41. Sitas F., Pacella-Norman R., Carrara H., Patel M., Ruff P., Sur R., Jentsch U., Hale M., Rowji P., Saffer D., Connor M., Bull D., Newton R., Beral V. The spectrum of HIV-1 related cancers in South Africa. Int. J. Cancer. 88:(3):2000;489-492.
42. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright jr T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. New Engl. J. Med. 337:1997;1343-1349.
43. Thomas D.B., Ray R.M., Kuypers J., Kiviat N., Koetsawang A., Ashley R.L., Qin Q., Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. III. Role of husbands and commercial sex workers. Am. J. Epidemiol. 153:(8):2001;740-748.
44. Vall Mayans M., Maguire A., Miret M., Casabona J. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain. Sex. Transmit. Dis. 26:1999;500-503.